PPT Slide

Goals for Next 12 Months

• Licensing of Novel Antibiotics

• Collaboration on Anti-Angiogenic Compounds

• Initiation of ISV-205 Phase III Clinical Trials

• Initiation of ISV-401 Clinical Trials

• Product Launch of ISV-900

• Additions to Management Team

• Strengthening Balance Sheet

Previous slide

Next slide

Back to first slide

View graphic version